SynthesisExpert review of clinical pharmacology2019

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis.

Anne Julienne Genuino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.